Table 4

Pre- and Post-Intervention Risk Factor Control Rates for Entire Phase Populations, by Study Arm and Priority Level
Study Facilities (n = 4) Control Facilities (n = 4)
PHASE Population Size 1 Pre-Intervention % in Control 2 Post-Intervention, % in Control 2 PHASE Population Size 1 Pre-Intervention % in Control 2 Post- Intervention % in Control 2
SBP ≥ 140 72,895 83.5 84.0 54,652 81.7 82.4
LDL-c ≥ 130 67,099 90.2 91.5 49,355 90.1 91.4
A1c ≥ 9% 48,464 90.9 91.0 38,497 90.3 90.7
SBP 130-139 72,895 61.1 62.8 54,652 60.7 62.6
LDL-c 100-129 67,099 71.8 75.3 49,355 71.7 75.5
A1c 7-8.9% 48,464 60.5 58.8 38,497 60.0 58.1

1 Members identified in Kaiser Permanente Northern California’s PHASE population from 1 year prior to the intervention to 1 year following the intervention, eligible for the priority by virtue of age and comorbidities, and with at least one risk factor measure in each period.

2 Control assessed based on latest recorded factor value during each period.

Selby et al.

Selby et al. BMC Health Services Research 2012 12:183   doi:10.1186/1472-6963-12-183

Open Data